Cell proliferation and tumour suppressor gene expression in iodine unstained area surrounding oral squamous cell carcinoma

International Journal of Oral and Maxillofacial Surgery

Volumn 33, Issue 1, 2004, Pages 75-83

  Yokoo, K ^a   Noma, H ^a   Inoue, T ^a   Hashimoto, S ^a   Shimono, Masaki ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Epithelial dysplasia; Iodine unstained area; p53; PAS histochemistry; Proliferating cell nuclear antigen; Ultrastructure

Indexed keywords

CYCLINE; GLYCOGEN; IODINE; PROTEIN P53;

ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRON MICROSCOPY; EPITHELIUM DYSPLASIA; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUTH CARCINOMA; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0347029692     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1054/ijom.2002.0457     Document Type: Article

References (37)

1. Akasaka Y, Okuda J, Ida K, Toriie S, Nishino H, Kimoto K. Vital staining of esophageal mucosa using endoscopic spraying technique of Lugol's solution - for the aid of esophagoscopic diagnosis of the cancer. Gastroenterol Endosc 1976: 18: 84-92.
2. Bravo R, Celis JE. A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol 1980: 84: 795-802.
3. Bravo R, Frank R, Blundell PA, MacDonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987: 326: 515-517.
4. Cahn LR, Eisenbud L, Blake MN. Histochemical analyses of white lesions of the mouth. II Analyses of glycogen content. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1962: 15: 458-462.
5. Califano J, Van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996: 56: 2488-2492.
6. Doyle JL, Manhold JH JR, Weisinger E. Study of glycogen content and "basement membrane" in benign and malignant oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1968: 26: 667-673.
7. Epstein JB, Scully C, Spinelli JJ. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992: 21: 160-163.
8. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with an altered half-life. Mol Cell Biol 1988: 8: 531-539.
9. Fregnani ER, Pires FR, Falzoni R, Lopes MA, Vargas PA. Lipomas of the oral cavity: clinical findings, histological classification and proliferative activity of 46 cases. Int J Oral Maxillofac Surg 2003: 32: 49-53.
10. Fujii Y, Satoh M. Immunohistochemical study of proliferating cell nuclear antigen (PCNA) and p53 protein in oral precancerous lesions and squamous cell carcinomas. Dent Jpn 1998: 34: 17-20.
11. Girod SC, Krueger G, Pape HD. p53 and Ki67 expression in preneoplastic and neoplastic lesions of the oral mucosa. Int J Oral Maxillofac Surg 1993: 22: 285-288.
12. Ha PK, Pilkington TA, Westra WH, Sciubba J, Sidransky D, Califano JA. Progression of microsatellite instability from premalignant lesions to tumors of the head and neck. Int J Cancer 2002: 102: 615-617.
13. Isacsson G, Shear M. Content and distribution of glycogen in oral epithelial dysplasia. Scand J Dent Res 1981: 89: 79-88.
14. Jorge J, Pires FR, Alves FA, Perez DE, Kowalski LP, Lopes MA. Juvenile intraoral pleomorphic adenoma: report of five cases and review of the literature. Int J Oral Maxillofac Surg 2002: 31: 273-275.
15. Kannan S, Yokozaki H, Jayasree K, Sebastian P, Mathews A, Abraham EK, Nair MK, Tahara E. Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancer. Int J Oral Maxillofac Surg 2002: 31: 414-418.
16. Kouno Y. Epithelial lesions around primary carcinoma of the oral mucosa. I Relationship between clinical findings and histopathologic structures. Jpn J Oral Maxillofac Surg 1982: 28: 6-15.
17. Kouzu T, Takahashi H, Onozawa K, Kuga K, Miyajima T, Hukao K, Akai H, Maruyama T, Hamano Y, Iino M, Horie H, Ishikawa T, Sato H, Isano K, Sato H. Experiences on endoscopical esophageal staining. Prog Digest Endosc 1975: 6: 41-44.
18. Kurita H, Kurashina K. Vital staining with iodine solution in delineating the border of oral dysplastic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996: 81: 275-280.
19. Kurokawa H, Yamashita Y, Takeda S, Miura K, Murata T, Kajiyama M. The expression of proliferating cell nuclear antigen (PCNA) and p53 protein correlate with prognosis of patients with oral squamous cell carcinoma. Fukuoka Acta Med 1999: 90: 6-13.
20. Mathews MB, Bernstein RM, Franza BR Jr, Garrels JI. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984: 309: 374-376.
21. Miyazaki S, Kawahara K, Watanabe S, Hirata M, Iida Y, Okita K, Okazaki Y, Takemoto T. Fundamental studies on Lugol staining method of esophageal carcinomas. Gastroenterol Endosc 1981: 23: 503-513.
22. Nagai N, Yonemoto Y, Nishijima K, Inoue M, Nagatsuka H. Immunohistochemical study of p53 and Rb tumor suppressor gene products in oral squamous cell carcinoma and epithelial dysplasia. J Okayama Dent Soc 1996: 15: 1-8.
23. Nishioka H, Kamibayashi T, Kirita T, Horiuchi K, Nakahashi K, Horiuchi K, Sugimura M, Matsuda H, Kitahori Y, Hiasa Y. Immunohistochemical analysis of p53 tumor suppressor gene product in oral squamous cell carcinoma: Comparison with PCNA stain and correlation with clinicopathologic findings. Jpn J Oral Maxillofac Surg 1993: 39: 201-206.
24. Nylander K, Nilsson P, Mehle C, Roos G. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. Br J Cancer 1995: 71: 826-830.
25. Ohki K, Kumamoto H, Ichinohasama R, Suzuki M, Yamaguchi T, Echigo S, Motegi K, Ooya K. Genetic analysis of DNA microsatellite loci in salivary gland tumours: comparison with immunohistochemical detection of hMSH2 and p53 proteins. Int J Oral Maxillofac Surg 2001: 30: 538-544.
26. Otsubo M. Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in oral squamous cell carcinoma. J Kyusyu Dent Soc 1995: 49: 108-120.
27. Pindborg JJ, Reichart PA, Smith CJ, Van der Waal I. Histological Typing of Cancer and Precancer of the Oral Mucosa. World Health Organization International Histological Classification of Tumors. 2nd edn. Berlin: Springer-Verlag 1997: 9-29.
28. Richart RM. A clinical staining test for the in vivo delineation of dysplasia and carcinoma-in-situ. Am J Obstet Gynecol 1963: 86: 703-712.
29. Sawadaishi K, Karaki Y, Kawaguchi M, Saitoh M, Saeki T, Yamada A, Shimazaki K, Munakata S, Sakamoto T, Shinbo T, Tazawa K, Fujimaki M. The examination of the coloring mechanism of the human esophageal epithelium by Lugol's solution. J Jpn Bronchoesophagol Soc 1989: 40: 252-257.
30. Schiller W. Early diagnosis of carcinoma of the cervix. Surg Gynecol Obstet 1933: 56: 210-222.
31. Silverman S Jr, Barvosa J, Kearns G. Ultrastructural and histochemical localization of glycogen in human normal and hyperkeratotic oral epithelium. Arch Oral Biol 1971: 16: 423-434.
32. Squier CA. Human Oral Mucosa. Development, Structure and Function. Oxford: Blackwell Scientific Publication 1976: 13-203.
33. Tsuboi S, Sato K, Nakajima K. The Contemporary Biochemistry. Tokyo: Kanehara Publishing 1992: 55-56.
34. Tsuji T, Miura Y, Wen X, Li A, Kanekawa K, Sasaki F, Shinozaki F. The significance of PCNA and p53 protein in some oral tumors. Int J Oral Maxillofac Surg 1995: 24: 221-225.
35. Tsuji T, Sasaki K, Kimura Y, Yamada K, Mori M, Shinozaki F. Measurement of proliferating cell nuclear antigen (PCNA) and its clinical application in oral cancers. Int J Oral Maxillofac Surg 1992: 21: 369-372.
36. Weiss MD, Weinmann JP, Meyer J. Degree of keratinization and glycogen content in the uninflamed and inflamed gingiva and alveolar mucosa. J Periodontol 1959: 30: 208-218.
37. Yonemoto Y, Nishijima K, Murata M, Nagai N. Immunohisto-chemical study of p53 tumor suppressor gene product and proliferating cell nuclear antigen in oral squamous cell carcinoma. Jpn J Oral Maxillofac Surg 1995: 41: 746-750.